Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

26 Scopus Citations
View graph of relations

Author(s)

  • Xin Liu
  • Emily K.Y. Lam
  • Xian Wang
  • Jianbin Zhang
  • Yuen Yee Cheng
  • Enders K.O. Ng
  • Jun Yu
  • Francis K.L. Chan
  • Hongchuan Jin
  • Joseph J.Y. Sung

Detail(s)

Original languageEnglish
Pages (from-to)242-248
Journal / PublicationTumor Biology
Volume30
Issue number5-6
Publication statusPublished - Dec 2009

Abstract

As an important way to inactivate tumor suppressor genes (TSGs) during cancer development, promoter hypermethylation can be used to define novel TSGs and identify biomarkers for cancer diagnosis. SLC19A3 (solute carrier family 19, member 3) was found to be such a biomarker. SLC19A3 expression was downregulated in gastric cancer cell lines (71%, 5/7) and restored after pharmacological demethylation. Notably, hypermethylation of SLC19A3 promoter was detected in gastric cancer cell lines (57%, 4/7), primary gastric carcinoma tissues (51%, 52/101) and precancerous lesion (intestinal metaplasia) tissues (32%, 8/25). Exogenous SLC19A3 expression caused growth inhibition of gastric cancer cells. In summary, SLC19A3 was epigenetically downregulated in gastric cancer. Methylation of SLC19A3 promoter could be a novel biomarker for early gastric cancer development. © 2009 S. Karger AG, Basel.

Research Area(s)

  • Gastric cancer, Methylation, SLC19A3

Citation Format(s)

Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer. / Liu, Xin; Lam, Emily K.Y.; Wang, Xian; Zhang, Jianbin; Cheng, Yuen Yee; Lam, Yun W.; Ng, Enders K.O.; Yu, Jun; Chan, Francis K.L.; Jin, Hongchuan; Sung, Joseph J.Y.

In: Tumor Biology, Vol. 30, No. 5-6, 12.2009, p. 242-248.

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review